#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	7522	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2850	777.3	0	.	n	.	0	C451T	SNP	451	451	C	1261	1261	T	1072	T,C	718,241	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	7522	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2850	777.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1994	1994	C	1014	C,T,G,A	908,2,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	7522	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2850	777.3	0	HET	.	.	.	C207T,A,G	.	207	207	C	1017	1017	C	1034	C,T,A,G	696,240,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	7522	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2850	777.3	0	HET	.	.	.	C328G,T,A	.	328	328	C	1138	1138	C	1050	C,G,T,A	718,250,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	7522	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2850	777.3	0	HET	.	.	.	C1450T	.	1450	1450	C	2260	2260	C	1135	C,T	776,275	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	12082	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4092	884.8	0	.	n	.	0	T695C	SNP	695	695	T	1277	1277	C	983	C,T	863,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	12082	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4092	884.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2553	2553	C	1073	C,A,T,G	965,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	12082	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4092	884.8	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3179	3179	T	1029	T,C	927,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	12082	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4092	884.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2627	2627	A	1109	A,C,G	1001,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1084	folP	855	855	100.0	folP.l15.c4.ctg.1	2034	159.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1227	1229	AGC	238;238;238	A;G,T;C	215;220,1;211	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3906	192.0	1	SNP	p	S91F	1	.	.	271	273	TTC	882	884	TTC	218;218;217	T;T;C	193;186;195	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3906	192.0	1	SNP	p	D95G	1	.	.	283	285	GGC	894	896	GGC	217;217;219	G,C;G;C	193,1;192;195	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3906	192.0	1	SNP	p	G95N	0	.	.	283	285	GGC	894	896	GGC	217;217;219	G,C;G;C	193,1;192;195	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1108	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1973	168.0	1	SNP	p	G45D	0	.	.	133	135	GGC	834	836	GGC	278;277;277	G;G,A;C	260;258,1;266	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	728	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	1528	142.4	0	.	n	.	0	A197.	DEL	197	197	A	787	787	A	269	A	253	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3398	239.7	1	SNP	p	D86N	0	.	.	256	258	GAC	832	834	GAC	303;302;303	G,T;A,C;C	269,1;265,1;282	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3398	239.7	1	SNP	p	R87I	0	.	.	259	261	CGT	835	837	CGT	304;303;303	C,A;G;T	278,1;277;271	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3398	239.7	1	SNP	p	R87W	0	.	.	259	261	CGT	835	837	CGT	304;303;303	C,A;G;T	278,1;277;271	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3398	239.7	1	SNP	p	S87R	1	.	.	259	261	CGT	835	837	CGT	304;303;303	C,A;G;T	278,1;277;271	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3398	239.7	1	SNP	p	S88P	0	.	.	262	264	TCC	838	840	TCC	305;307;308	T;C;C,A	278;281;280,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2252	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3380	199.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1922	1924	GGC	271;269;267	G;G,C;C,A	241;240,1;232,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2000	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2913	205.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1577	1579	GCC	280;279;281	G;C;C,A	257;250;259,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2000	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2913	205.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1580	1582	ATG	281;281;281	A;T;G,T	259;253;253,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2000	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2913	205.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1592	1594	ACC	279;279;280	A;C,T;C,G	254;254,3;257,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2000	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2913	205.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1592	1594	ACC	279;279;280	A;C,T;C,G	254;254,3;257,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2000	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2913	205.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2093	2095	ACC	261;262;261	A;C,A;C,A	243;231,1;236,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2000	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2913	205.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2147	2149	GCG	256;255;255	G;C,A;G	234;231,1;226	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2000	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2913	205.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2147	2149	GCG	256;255;255	G;C,A;G	234;231,1;226	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2000	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2913	205.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2270	2272	GGT	268;267;269	G;G;T	244;243;244	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2000	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2913	205.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2279	2281	AGC	265;265;265	A,T;G;C,A	238,1;241;239,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2000	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2913	205.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2297	2299	CCG	268;269;268	C,G;C;G,C	228,1;232;226,3	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	2666	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3518	226.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1876	1878	CCG	256;256;256	C;C,A;G	220;220,1;217	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1346	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2567	157.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	957	957	C	211	C	194	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	240	porB1a	984	319	90.43	porB1a.l15.c4.ctg.1	1542	45.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1247	1249	AAT	36;37;37	A;A;T	31;34;33	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	240	porB1a	984	319	90.43	porB1a.l15.c4.ctg.1	1542	45.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1250	1252	AAT	37;37;37	A;A;T	34;31;32	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	240	porB1a	984	319	90.43	porB1a.l15.c4.ctg.1	1542	45.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1274	1276	GCA	34;34;34	G;C;A	33;31;34	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	240	porB1a	984	319	90.43	porB1a.l15.c4.ctg.1	1542	45.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1297	1299	GTA	30;30;28	G;T;A	28;28;28	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	240	porB1a	984	319	90.43	porB1a.l15.c4.ctg.1	1542	45.8	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1306	1306	A	24	A	24	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1542	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	1899	238.4	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1116	1118	AGA	350;349;346	A;G,A;A	312;309,1;305	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1542	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	1899	238.4	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1137	1139	GGT	340;337;337	G,T;G,A;T	308,1;303,1;311	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1542	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	1899	238.4	1	SNP	p	G120K	1	.	.	358	360	AAG	846	848	AAG	335;335;332	A;A,C;G,A	307;304,2;294,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1542	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	1899	238.4	1	SNP	p	N121D	0	.	.	361	363	AAC	849	851	AAC	331;332;332	A;A;C,A	296;303;305,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1542	porB1b	1038	1038	99.81	porB1b.l6.c30.ctg.1	1899	238.4	1	SNP	p	A121N	1	.	.	361	363	AAC	849	851	AAC	331;332;332	A;A;C,A	296;303;305,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	4896	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5433	270.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	814	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1452	166.4	1	SNP	p	V57M	1	.	.	169	171	ATG	737	739	ATG	279;279;281	A;T;G,T	252;256;259,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
